内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Taich Adam. Director active across 2 companies, notably 10x Genomics, Inc.. In total, 13 reports have been logged. Split: 0 buy · 10 sells. Total volume traded: €4.5m. History available since 2 March 2023. The latest transaction was disclosed on 9 September 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Taich Adam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
1,206 股@ US$63.6774Class A Common StockSEC:0001610717-26-000414:0
31,428 股@ US$64.3097Class A Common StockSEC:0001610717-26-000414:1
13,754 股@ US$65.2574Class A Common StockSEC:0001610717-26-000414:2
17,166 股@ US$63.0230.013% mcap33.1% 占其流量Class A Common StockSEC:0001610717-26-000391:0
15,098 股@ US$24.44150.0049% mcap39.3% 占其流量Class A Common StockSEC:0001610717-26-000162:0
106,579 股0Class A Common StockSEC:0001610717-26-000075:0
8,968 股@ US$18.576414.8% 占其流量Class A Common StockSEC:0001610717-26-000069:0
11,888 股@ US$18.998324.3% 占其流量Class A Common StockSEC:0001610717-25-000400:0
22,315 股@ US$13.78732.8% 占其流量Class A Common StockSEC:0001610717-25-000320:0
4,044 股@ US$8.29933.7% 占其流量Class A Common StockSEC:0001610717-25-000142:0
201,704 股0Class A Common StockSEC:0001610717-25-000073:0
48,425 股Common StockSEC:0001209191-24-001334:0
1,412 股@ US$2.5576100.0% 占其流量Common StockSEC:0001209191-23-051196:0
About Taich Adam
Taich Adam is Chief Financial Officer at 10x Genomics, Inc. and Interim CEO at SomaLogic, Inc. Across 9 filings in total, the 9 sampled filings, from 2023-10-02 to 2026-05-27, report only sales for a total of EUR 952626, with 10x Genomics, Inc. as the most frequently mentioned company.